Severe Acute Respiratory Syndrome: all 386 studies

Page 3 of 4. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.

• Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy PopulationCompletedNCT04649021Phase 2
• Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in PolandStatus unknownNCT04648800Phase 3
• Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19]CompletedNCT04644159
• An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult VolunteersStatus unknownNCT04641481Phase 3
• Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT)CompletedNCT04636671Phase 3
• Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19CompletedNCT04635943Phase 2
• Serological Diagnostics of COVID-19 in Health Care WorkersStatus unknownNCT04635592
• Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 SubjectsCompletedNCT04629703Phase 3
• Prevalence and Risk Factors of COVID-19 in the Upper Silesian AgglomerationStatus unknownNCT04627623
• Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2WithdrawnNCT04626089Phase 2
• International Registry of Healthcare Workers Exposed to COVID-19 Patients (UNITY Global)CompletedNCT04626076
• Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2.CompletedNCT04625985Phase 2
• A Virtual Prospective Study Exploring Activity Trackers and COVID-19 InfectionsCompletedNCT04623138
• IVIG in Patients With Severe COVID-19 Requiring Mechanical VentilationStatus unknownNCT04616001Phase 4
• Home-based Exercise in COVID-19 SurvivorsStatus unknownNCT04615052Not applicable
• Sero-prevalence COVID-19 Among Belgian ChildrenCompletedNCT04613817
• Efficacy and Safety of Favipiravir in Covid-19 Patients in IndonesiaCompletedNCT04613271Phase 3
• A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2CompletedNCT04611802Phase 3
• A Study to Assess Infection Rate of Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2) and It's Affect on Quality of Life in Adult Volunteers in Lake County, IllinoisCompletedNCT04611230
• Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus of Coronavirus Disease 2019CompletedNCT04609774
• Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?TerminatedNCT04606563Phase 3
• Inhaled NO for the Treatment of Viral Pneumonia in AdultsCompletedNCT04606407Not applicable
• Self-Collected Saliva Samples Without Viral Transport Media for COVID-19 Testing Via RT-PCRCompletedNCT04604145Not applicable
• Electrical Impedance Tomography: Collapse in Dependent Areas as a Predictor of Response to Prone Position Ventilation in COVID-19 Acute Respiratory Distress SyndromeCompletedNCT04603755
• Ivermectin in Adults With Severe COVID-19.TerminatedNCT04602507Phase 2
• Communication in ICU During COVID-19CompletedNCT04602351
• Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit PatientsCompletedNCT04598594Phase 3
• Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19CompletedNCT04598581Not applicable
• Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure ProphylaxisStatus unknownNCT04597775Phase 2/3
• Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)WithdrawnNCT04590274Phase 1
• COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-CCompletedNCT04588363
• Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study)CompletedNCT04584658
• Efficacy of Nicotine in Preventing COVID-19 InfectionStatus unknownNCT04583410Phase 3
• Prevalence of Antibodies Against SARS-CoV-2 Virus That Causes COVID-19 in Tübingen ChildrenCompletedNCT04581889
• A Registry Study of COVID-19 Serologic and Virologic Testing to Accelerate Recovery and TransitionWithdrawnNCT04573634
• GM-CSF Inhalation to Prevent ARDS in COVID-19 PneumoniaCompletedNCT04569877Phase 2
• Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19)CompletedNCT04567810Phase 1
• Serology to COVID-19 for Recording Exposures and Evaluating NeedsTerminatedNCT04566965
• Corona Virus Infection Among Liver Transplant RecipientsStatus unknownNCT04565782
• Convalescent Plasma Therapy for COVID-19 PatientsStatus unknownNCT04565197Early Phase 1
• Study of Oral Administration of Ribavirin and Nitazoxamide Versus Placebo in COVID-19CompletedNCT04563208Phase 2
• COVID-19 Prophylaxis South Africa (COVER HCW)CompletedNCT04561063Phase 2
• High Flow Nasal Cannula HFNC In Covid-19 PatientsStatus unknownNCT04560257Not applicable
• Remdesivir in COVID-19 Lahore General HospitalStatus unknownNCT04560231Early Phase 1
• Tocilizumab in COVID-19 Lahore General HospitalStatus unknownNCT04560205Phase 1
• Methylprednisolone in COVID-19 Patients (Methyl19LGH)Status unknownNCT04559113Not applicable
• Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical VentilationCompletedNCT04558476Phase 2
• The Containing Coronavirus Disease 19 (COVID-19) TrialCompletedNCT04552379Phase 3
• Study of the Analytical Performance of Different Salivary Self-collection Methods for the Detection of COVID-19CompletedNCT04550390
• Recovery of Exertion Ability Following COVID-19 Infection in Military StaffStatus unknownNCT04548505
• COVID-19 Persistence in StoolCompletedNCT04546776
• Pediatric Intensive Care and COVID-19Status unknownNCT04544878
• Analysis of the Quality and Quantity of Antibiotic Prescriptions for Bacterial Respiratory Tract Superinfection in Patients Hospitalized in COVID-19 WardsStatus unknownNCT04544072
• Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc TherapyTerminatedNCT04542993Phase 2
• COVID-19-Related Health and Practices Among Dental HygienistsCompletedNCT04542915
• COVID-19 IgG Formation in Physicians at ALGH and Their Household MembersCompletedNCT04540484
• A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19Status unknownNCT04540185Phase 3
• COVID-19 Testing Sample Acquisition Throughput and EfficiencyCompletedNCT04532411
• Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19Status unknownNCT04530578Phase 4
• The Effect of Melatonin and Vitamin C on COVID-19CompletedNCT04530539Not applicable
• Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic DiseasesStatus unknownNCT04530461
• Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 VaccineCompletedNCT04530357Phase 1/2
• Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 InfectionStatus unknownNCT04528888Phase 3
• COVID-19 Health Professional Impact StudyCompletedNCT04527432Not applicable
• High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center StudyCompletedNCT04525820Not applicable
• MOIST Study: Multi-Organ Imaging With Serial Testing in COVID-19 Infected PatientsCompletedNCT04525404
• An Exploratory Study of ADR-001 in Patients with Severe Pneumonia Caused by SARS-CoV-2 InfectionCompletedNCT04522986Phase 1
• SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 PatientsCompletedNCT04521309Phase 1/2
• Antibodies Responses to COVID-19 Infection in Hospitalized PatientsStatus unknownNCT04520880
• Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in ColombiaStatus unknownNCT04519125Phase 2/3
• Renal Biomarkers in AKI and COVID-19CompletedNCT04517630
• Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19CompletedNCT04517422Not applicable
• Impact of Perceived Control on Operational Strain: a Study of COVID-19 Pandemic Caregivers and Military Personnel on Operational MissionsStatus unknownNCT04517136
• CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19TerminatedNCT04516941Phase 3
• Study of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools PersonnelCompletedNCT04516928
• Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020CompletedNCT04514874
• Cross Sectional CFAR HIV/COVID-19 StudyCompletedNCT04514016
• Characterizing the Immune Response and Neuronal Damage in COVID-19CompletedNCT04510012
• Psychological Impact of COVID-19 Pandemic in Healthcare WorkersCompletedNCT04506515
• Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19)Status unknownNCT04497454Not applicable
• Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDSCompletedNCT04494386Phase 1/2
• COVID-19 Seroprevalence Study in French GuianaCompletedNCT04490850Not applicable
• Turkish of the SARS-CoV-2 Anxiety ScaleStatus unknownNCT04490473Not applicable
• Effectiveness of a Novel Respirator With Chitosan NanoparticlesCompletedNCT04490200Not applicable
• Tele-health Enabled Clinical Trial for COVID-19WithdrawnNCT04489628Phase 1/2
• Trial of Combination Therapy to Treat COVID-19 InfectionCompletedNCT04482686Phase 1
• Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for SurgeryCompletedNCT04480580
• Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831Status unknownNCT04480333Phase 1
• Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil)CompletedNCT04479488
• Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19TerminatedNCT04477993Phase 2/3
• Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19CompletedNCT04476979Phase 2
• Influence of Military Preventive Policy for reCruit Training on COVID-19 SeroconversionStatus unknownNCT04476680Not applicable
• Can the Electronic Nose Smell COVID-19 Antibodies?CompletedNCT04475575Not applicable
• Can the Electronic Nose Smell COVID-19?CompletedNCT04475562Not applicable
• Epidemiologic Assessment of SARS-CoV-2 (COVID-19) Prevalence in MinnesotaWithdrawnNCT04473183
• Italian Web-based Cross-sectional Survey on COVID-19CompletedNCT04471701
• Treatment of Critically Ill Patients With Covid-19 With Convalescent PlasmaCompletedNCT04468009Phase 2
• Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb TrialCompletedNCT04466241Phase 2/3
• Northeast COVID-19 and Pregnancy Study GroupActive, not recruitingNCT04462367
• A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult VolunteersCompletedNCT04461353Phase 1

← Severe Acute Respiratory Syndrome overview